更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
基因疗法细胞培养基市场主要企业——龙沙公司 - openPR.com
Gene Therapy Cell Culture Media Market By Top Companies-Lonza openPR.com
龙沙扩大其细胞与基因疗法GMP解决方案——精选科学报道
Lonza expands its GMP solutions for cell and gene therapy SelectScience
龙沙扩大细胞与基因治疗产品组合 - 合同制药
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
龙沙旗下Synaffix与Qurient Therapeutics合作开发双载荷ADC技术——GEN生物工程与生物技术新闻
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development GEN - Genetic Engineering and Biotechnology News
龙沙同意扩大RION基于外泌体疗法的生产规模——GEN《基因工程与生物技术新闻》报道
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
2025年十大合同开发与生产组织 - 基因工程与生物技术新闻
Top 10 Contract Development and Manufacturing Organizations 2025 GEN - Genetic Engineering and Biotechnology News
龙沙集团UC-II胶原蛋白获NutraStrong认证,临床证据支持其对膝关节灵活性的益处——营养展望
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility Nutritional Outlook
Lonza CHI获得NutraStrong胶原蛋白认证——营养视野网报道
Lonza CHI receives NutraStrong Collagen Verified certification nutritioninsight.com
SGS Nutrasource授予Lonza胶囊与健康成分NutraStrong胶原蛋白认证——营养保健品行业评论
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients Nutraceutical Business Review
ToolGen在荷兰对Lonza提起专利侵权诉讼 - PR Newswire
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands PR Newswire
瑞士公司收购基因泰克瓦卡维尔工厂——运营现状如何 - 旧金山商业时报 - 商业期刊
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times The Business Journals
龙沙高管谈生产准备:应对细胞与基因疗法挑战——亚洲生物科技视野
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge BioSpectrum Asia
Ethris与Lonza合作开发用于预防呼吸道疾病的喷雾干燥mRNA疫苗——GEN生物技术新闻
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention GEN - Genetic Engineering and Biotechnology News
Exogenus Therapeutics选定龙沙集团生产Exo-101——合同制药
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
Exogenus Therapeutics与Lonza合作开发符合GMP标准的主要外泌体候选药物生产工艺 - 基因工程与生物技术新闻
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate GEN - Genetic Engineering and Biotechnology News
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页